trending Market Intelligence /marketintelligence/en/news-insights/trending/JDi5cVD1uQmSHiBagZqbdQ2 content esgSubNav
In This List

EyeGate prices $10M common stock, warrants offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


EyeGate prices $10M common stock, warrants offering

Eyegate Pharmaceuticals Inc. is looking to raise $10 million via a public offering.

The company will issue 6,666,667 shares at $1.50 apiece, complete with warrants to purchase an additional 6,666,667 stock within five years from the date of issue at the same price.

EyeGate plans to use the net proceeds for clinical trials, working capital and general corporate purposes.

Rodman & Renshaw is acting as the exclusive placement agent for the offering which is expected to close by June 14.